CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- 4/A Open-market sale GENERAL COUNSEL sold 2,412 shares at $2.91 ($7,019)
- 4/A Open-market sale CFO AND CHIEF BUSINESS OFFICER sold 1,208 shares at $2.91 ($3,515)
- 4/A Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,412 shares at $2.91 ($7,019)
- 4 Grant or award Chief Medical Officer acquired 10,000 shares (grant or award)
- 4 Open-market sale Gengos Andrew sold 1,208 shares at $2.91 ($3,515)
- 4 Open-market sale Chief Executive Officer sold 4,820 shares at $2.91 ($14,026)
- 4 Open-market sale General Counsel sold 2,412 shares at $2.91 ($7,019)
- 4 Open-market sale Chief Scientific Officer sold 2,412 shares at $2.91 ($7,019)
- 4 Open-market sale Chief Operating Officer sold 2,412 shares at $2.91 ($7,019)
- 4 Open-market buy Director bought 605,686 shares at an average $2.42 ($1,462,895)
- 4 Open-market buy Gengos Andrew bought 15,000 shares at an average $3.43 ($51,445)
- 4 Open-market buy Gengos Andrew bought 65,012 shares at an average $2.95 ($191,572)
- 4 Grant or award Chief Medical Officer acquired 7,764 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 11 · 211 filings